ESBL  	ESBL  	 NNP	B-NP
and  	and  	 CC	O
carbapenemases  	carbapenemases  	 NN	B-NP
in  	in  	 IN	O
Enterobacteriaceae  	Enterobacteriaceae  	 NNP	B-NP
Carbapenemase-producing  	Carbapenemase-producing  	 JJ	I-NP
enterobacteria  	enterobacteria  	 NNS	I-NP
( 	( 	 -LRB-	O
CPE 	CPE 	 NNP	B-NP
)  	)  	 -RRB-	O
spread  	spread  	 VBD	O
all  	all  	 DT	O
over  	over  	 IN	O
the  	the  	 DT	O
world  	world  	 NN	O
during  	during  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
years 	years 	 NNS	O
,  	,  	 ,	O
causing  	causing  	 VBG	O
serious  	serious  	 JJ	B-NP
infections  	infections  	 NNS	I-NP
with  	with  	 IN	O
increasing  	increasing  	 VBG	B-NP
frequency 	frequency 	 NN	I-NP
.  	.  	 .	O
Very  	Very  	 RB	O
few  	few  	 JJ	O
new  	new  	 JJ	O
drugs  	drugs  	 NNS	O
active  	active  	 JJ	O
against  	against  	 IN	O
CPE  	CPE  	 NNP	B-NP
are  	are  	 VBP	O
expected  	expected  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
clinically  	clinically  	 RB	O
available 	available 	 JJ	O
.  	.  	 .	O
Studies  	Studies  	 NNS	O
summarized  	summarized  	 VBD	O
in  	in  	 IN	O
this  	this  	 DT	O
review  	review  	 NN	B-NP
show  	show  	 NN	I-NP
that  	that  	 IN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
yet  	yet  	 RB	O
room  	room  	 NN	O
to  	to  	 TO	O
improve  	improve  	 VB	O
our  	our  	 PRP$	O
therapeutic  	therapeutic  	 JJ	B-NP
approaches 	approaches 	 NNS	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
infections  	infections  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
CPE 	CPE 	 NNP	B-NP
.  	.  	 .	O
